CEREBRAL PROTECTION & RECOVERY AFTER CIRCULATORY ARREST
大脑保护
基本信息
- 批准号:6135736
- 负责人:
- 金额:$ 5.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-02-01 至 2003-01-31
- 项目状态:已结题
- 来源:
- 关键词:AMPA receptors NMDA receptors adenosine triphosphate antioxidants artificial respiration bioenergetics body temperature body water brain metabolism cardiopulmonary resuscitation cerebral ischemia /hypoxia cytotoxicity disease /disorder model heart arrest histopathology homeostasis immunocytochemistry laboratory rat magnetic resonance imaging neuroprotectants neuropsychological tests nuclear magnetic resonance spectroscopy
项目摘要
DESCRIPTION: (Adapted from the applicant's abstract) The PI proposes
technologically intense, NMR/MRI based investigations of cardiac arrest
using a new, clinically relevant rat cardiac arrest model. MRI/MRS data
will be correlated with histopathologic and neurobehavioral outcomes.
State-of-the-art interleaved multi-nuclear magnetic resonance spectroscopy
and imaging are conducted in a customized 9.4 Tesla instrument with powerful
gradient coils. Diffusion-weighted MR-imaging is used to detect rapid
changes in brain edema, and spin-tagging of blood is used for perfusion
imaging of the brain. Cardiac arrest will be induced by controlled
asphyxiation in anesthetized, normothermic rats. Resuscitation will occur
at four predetermined time points (12, 16, 20 and 24 minutes) after cardiac
arrest. All events will occur inside a superwide-bore, 9.4 Tesla
high-resolution NMR spectrometer, during which time MRI and MRS measurements
will be continually made of rCBF, cerebral ion and water homeostasis, and
brain metabolism. Measurements will be made before, during, and after
cardiac arrest and resuscitation. Pre- and post-arrest pharmacological
treatments will combine three classes of novel neuroprotective agents: (i)
agents that improve cerebral energy metabolism, (ii) antioxidants that
inhibit iron-dependent lipid peroxidation and key enzymes of the arachidonic
acid cascade, and (iii) glutamate receptor antagonists that mitigate
excitotoxicity injury. Seven series of experiments are proposed. The four
specific aims are: (1) to correlate changes caused by global ischemia in
cerebral perfusion, water homeostasis, and energy metabolism, with brain
damage and neurologic outcome; (2) to correlate energy metabolism and water
homeostasis with post-resuscitation hypoperfusion; (3) to study the effects
of antioxidants on reperfusion injury; and (4) to study glutamate
excitotoxicity in global ischemia.
描述:(改编自申请人摘要)PI建议
基于核磁共振/核磁共振成像的技术密集型心脏骤停研究
使用一种新的临床相关的大鼠心脏骤停模型。 MRI/MRS数据
将与组织病理学和神经行为结果相关。
最先进的交错多核磁共振波谱技术
在定制的9.4特斯拉仪器中进行成像,
梯度线圈 弥散加权磁共振成像用于检测快速
脑水肿的变化,血液自旋标记用于灌注
大脑成像。 心脏骤停将通过控制
窒息在麻醉,常温大鼠。 复苏将会发生
在心脏起搏后的四个预定时间点(12、16、20和24分钟),
逮捕了 所有事件都将发生在一个9.4特斯拉的超大口径
高分辨率NMR光谱仪,在此期间,MRI和MRS测量
将持续由rCBF、脑离子和水稳态组成,
脑代谢 测量将在之前、期间和之后进行
心脏骤停和复苏 停搏前和停搏后药理学
治疗将结合联合收割机三类新的神经保护剂:(i)
改善脑能量代谢的药剂,(ii)抗氧化剂,
抑制铁依赖性脂质过氧化和花生四烯酸关键酶
酸级联,和(iii)谷氨酸受体拮抗剂,其减轻
兴奋性毒性损伤 提出了七个系列的实验。 四
具体的目的是:(1)将由全脑缺血引起的变化与
脑灌注、水稳态和能量代谢,
损害和神经功能的结果;(2)能量代谢和水的相关性
复苏后低灌注状态下的体内平衡;(3)研究复苏后低灌注状态下,
抗氧化剂对再灌注损伤的影响;(4)研究谷氨酸
兴奋性毒性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YAN XU其他文献
YAN XU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YAN XU', 18)}}的其他基金
Peripheral and Central Pathways of α3 Glycine Receptors as Non-Opioid Molecular Targets to Treat Pain
α3 甘氨酸受体的外周和中枢通路作为非阿片类药物分子靶点治疗疼痛
- 批准号:
10612086 - 财政年份:2022
- 资助金额:
$ 5.6万 - 项目类别:
Peripheral and Central Pathways of α3 Glycine Receptors as Non-Opioid Molecular Targets to Treat Pain
α3 甘氨酸受体的外周和中枢通路作为非阿片类药物分子靶点治疗疼痛
- 批准号:
10445387 - 财政年份:2022
- 资助金额:
$ 5.6万 - 项目类别:
Uterine signaling networks in the pathogenesis of pulmonary lymphangioleiomyomatosis (LAM)
肺淋巴管平滑肌瘤病 (LAM) 发病机制中的子宫信号网络
- 批准号:
10447086 - 财政年份:2020
- 资助金额:
$ 5.6万 - 项目类别:
Uterine signaling networks in the pathogenesis of pulmonary lymphangioleiomyomatosis (LAM)
肺淋巴管平滑肌瘤病 (LAM) 发病机制中的子宫信号网络
- 批准号:
10221045 - 财政年份:2020
- 资助金额:
$ 5.6万 - 项目类别:
Uterine signaling networks in the pathogenesis of pulmonary lymphangioleiomyomatosis (LAM)
肺淋巴管平滑肌瘤病 (LAM) 发病机制中的子宫信号网络
- 批准号:
10027128 - 财政年份:2020
- 资助金额:
$ 5.6万 - 项目类别:
Uterine signaling networks in the pathogenesis of pulmonary lymphangioleiomyomatosis (LAM)
肺淋巴管平滑肌瘤病 (LAM) 发病机制中的子宫信号网络
- 批准号:
10633293 - 财政年份:2020
- 资助金额:
$ 5.6万 - 项目类别:
Role of immune cell OGR1 in prostate cancer development and the mechanisms involv
免疫细胞OGR1在前列腺癌发生发展中的作用及其机制
- 批准号:
8843380 - 财政年份:2011
- 资助金额:
$ 5.6万 - 项目类别:
相似海外基金
Regulation of GluN2B-NMDA Receptors by Interactions with the Actin Cytoskeleton
通过与肌动蛋白细胞骨架相互作用调节 GluN2B-NMDA 受体
- 批准号:
10606121 - 财政年份:2023
- 资助金额:
$ 5.6万 - 项目类别:
Network activity and the role of NMDA receptors in associative learning
网络活动和 NMDA 受体在联想学习中的作用
- 批准号:
DP220102377 - 财政年份:2022
- 资助金额:
$ 5.6万 - 项目类别:
Discovery Projects
Non-canonical signaling by NMDA receptors in the Fragile X brain
脆性 X 脑中 NMDA 受体的非规范信号传导
- 批准号:
464946 - 财政年份:2022
- 资助金额:
$ 5.6万 - 项目类别:
Operating Grants
Exploring the mysterious role of astrocytic NMDA receptors from behavioural to biochemical levels.
从行为到生化水平探索星形细胞NMDA受体的神秘作用。
- 批准号:
547576-2020 - 财政年份:2022
- 资助金额:
$ 5.6万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Doctoral
Precision Targeting of Heteromeric NMDA Receptors in Age-Related Memory Disorders
异聚 NMDA 受体在年龄相关记忆障碍中的精确靶向
- 批准号:
10624058 - 财政年份:2022
- 资助金额:
$ 5.6万 - 项目类别:
Molecular pathways connecting NMDA receptors to the actin cytoskeleton
连接 NMDA 受体与肌动蛋白细胞骨架的分子途径
- 批准号:
RGPIN-2018-06409 - 财政年份:2022
- 资助金额:
$ 5.6万 - 项目类别:
Discovery Grants Program - Individual
Extrasynaptic NMDA receptors and resilience to chronic stress
突触外 NMDA 受体和慢性应激恢复能力
- 批准号:
462065 - 财政年份:2022
- 资助金额:
$ 5.6万 - 项目类别:
Operating Grants